Roche cobas p 612 pre-analytical system (63x) Model: 07563116001 The cobas p 612 pre-analyti...
FDA Device Recall #Z-2944-2018 — Class II — July 16, 2018
Recall Summary
| Recall Number | Z-2944-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 16, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Roche Diagnostics Corporation |
| Location | Indianapolis, IN |
| Product Type | Devices |
| Quantity | 12 units |
Product Description
Roche cobas p 612 pre-analytical system (63x) Model: 07563116001 The cobas p 612 pre-analytical system is a computer controlled fully automatic system for sorting of open and closed barcoded and centrifuged and non-centrifuged sample tubes. The cobas p 612 is intended for use with analyzers that perform tests in the area of clinical chemistry, immuno chemistry, coagulation, hematology, urinalysis, nucleic acid testing.
Reason for Recall
Sample material may potentially come in contact with the pipetting nozzle during operation of cobas p 612 pre-analytical system (63x) (LCP1) with non-filter tips. The possible presence of biological material on the nozzle may cause contamination resulting in potential false positive results, depending on the sensitivity of the analytical technology.
Distribution Pattern
US Distribution to states of: CA, NY,TX, WA, and WI.
Lot / Code Information
All units
Other Recalls from Roche Diagnostics Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1979-2019 | Class II | The Tina-quant lgA Gen.2 is an immunoturbidimet... | Jun 3, 2019 |
| Z-1928-2019 | Class III | cobas p 701 post-analytical units, Part Number ... | Apr 4, 2019 |
| Z-1927-2019 | Class III | cobas p 501 post-analytical units, Part Number ... | Apr 4, 2019 |
| Z-1194-2019 | Class II | Albumin BCP Product Usage: ALBP is an in v... | Mar 18, 2019 |
| Z-1249-2019 | Class II | cobas e 801 immunoassay analyzer | Mar 15, 2019 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.